Dr Reddys Laboratories (RDY) Return on Equity [ROE] (2009 - 2026)
Dr Reddys Laboratories' Return on Equity [ROE] came in at 107.62% for the quarter ended Jun 30, 2026, up 95.07 percentage points from 12.55% a year earlier but down 1.11 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Dr Reddys Laboratories' Return on Equity [ROE] was 11.30%, down 7.22 percentage points from the prior year.
- Return on Equity [ROE] carries a five-year change of +0.62 percentage points (years ended Mar 2021 to Mar 2026).
- Going back by year, Return on Equity [ROE] was 18.52% in the year ended Mar 31, 2025 (-3.09 pp), 21.61% in the year ended Mar 31, 2024 (+1.04 pp), 20.58% in the year ended Mar 31, 2023 (+7.82 pp) and 12.75% in the year ended Mar 31, 2022 (+2.08 pp).
- The five-year range for quarterly Return on Equity [ROE] is 9.20% (the quarter ended Sep 30, 2024) to 108.72% (the quarter ended Mar 31, 2026).
- Year-over-year, Return on Equity [ROE] has increased for six consecutive quarters, with an average year-over-year change of +27.44 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in the quarter ended Mar 31, 2026 (a gain of 95.59 percentage points), and the weakest in the quarter ended Sep 30, 2024 (a drop of 12.06 percentage points).
- Business Quant data shows RDY's Return on Equity [ROE] at 108.72% (quarter ended Mar 31, 2026), 50.44% (quarter ended Dec 31, 2025) and 12.24% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | 107.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.62% |
| Mar 31, 2026 | 108.72% |
| Dec 31, 2025 | 50.44% |
| Sep 30, 2025 | 12.24% |
| Jun 30, 2025 | 12.55% |
| Mar 31, 2025 | 13.14% |
| Dec 31, 2024 | 12.97% |
| Sep 30, 2024 | 9.20% |
| Jun 30, 2024 | 10.16% |
| Mar 31, 2024 | 10.99% |
| Dec 31, 2023 | 17.14% |
| Sep 30, 2023 | 21.26% |
| Jun 30, 2023 | 21.25% |
| Mar 31, 2023 | 21.56% |
| Dec 31, 2022 | 16.50% |
| Sep 30, 2022 | 14.54% |
| Jun 30, 2022 | 12.33% |
| Mar 31, 2022 | 11.31% |
| Dec 31, 2021 | 14.03% |
| Sep 30, 2021 | 16.66% |
API Access
Dr Reddys Laboratories Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();